Zhou-Shan Tao1, Yang-Xun Lv1, Wei Cui1, Zheng-Liang Huang1, Kai-Kai Tu1, Qiang Zhou1, Tao Sun1, Lei Yang2. 1. Department of Orthopaedic Surgery, Second Affiliated Hospital of Wenzhou Medical University, 325027, Wenzhou, People's Republic of China. 2. Department of Orthopaedic Surgery, Second Affiliated Hospital of Wenzhou Medical University, 325027, Wenzhou, People's Republic of China. tzs19900327@163.com.
Abstract
OBJECTIVE: This study aimed to investigate the effect exerted by teriparatide on the repair of femoral metaphyseal defect in ovariectomized rats. METHOD: Female Sprague-Dawley rats were ovariectomized and after 3 months a critically sized defect of 3 mm in diameter-a through-hole bone defect-was drilled into each distal femur of the ovariectomized rats. The rats were injected with teriparatide (30 μg/kg) parathyroid hormone (PTH) in the peritoneum three times per week. After 4 and 8 weeks the animals were killed and the blood and bilateral femora were harvested for biochemical analysis, histopathological observation, and micro-computed tomography (CT) examination. RESULTS: The PTH group and control group were compared 4 and 8 weeks after surgery. PTH increased bone formation in the defect area. Moreover, PTH showed the strongest effects on bone volume per total volume, trabecular number, trabecular thickness, trabecular separation, and total fluorescence-marked new bone area. Additionally, the PTH treatment group showed inhibited serum concentrations of C-terminal telopeptide of type I collagen and enhanced expression of calcium, phosphorus, and bone alkaline phosphatase. CONCLUSION: Our findings suggest a positive effect of PTH on defect healing in ovariectomized rats.
OBJECTIVE: This study aimed to investigate the effect exerted by teriparatide on the repair of femoral metaphyseal defect in ovariectomized rats. METHOD: Female Sprague-Dawley rats were ovariectomized and after 3 months a critically sized defect of 3 mm in diameter-a through-hole bone defect-was drilled into each distal femur of the ovariectomized rats. The rats were injected with teriparatide (30 μg/kg) parathyroid hormone (PTH) in the peritoneum three times per week. After 4 and 8 weeks the animals were killed and the blood and bilateral femora were harvested for biochemical analysis, histopathological observation, and micro-computed tomography (CT) examination. RESULTS: The PTH group and control group were compared 4 and 8 weeks after surgery. PTH increased bone formation in the defect area. Moreover, PTH showed the strongest effects on bone volume per total volume, trabecular number, trabecular thickness, trabecular separation, and total fluorescence-marked new bone area. Additionally, the PTH treatment group showed inhibited serum concentrations of C-terminal telopeptide of type I collagen and enhanced expression of calcium, phosphorus, and bone alkaline phosphatase. CONCLUSION: Our findings suggest a positive effect of PTH on defect healing in ovariectomized rats.
Entities:
Keywords:
Bone defect; Bone mineralization; Micro-computed tomography; New bone; Osteoporosis
Authors: Robinder S Dhillon; Chao Xie; Wakenda Tyler; Laura M Calvi; Hani A Awad; Michael J Zuscik; Regis J O'Keefe; Edward M Schwarz Journal: J Bone Miner Res Date: 2013-03 Impact factor: 6.741
Authors: Ning Cheng; Jing Dai; Xiangrong Cheng; Shu'e Li; Richard J Miron; Tao Wu; Wenli Chen; Yufeng Zhang; Bin Shi Journal: J Mater Sci Mater Med Date: 2013-05-15 Impact factor: 3.896